Joseph L. Kim - Natick MA, US Kurt Morgenstern - Derry NH, US Paul Caron - Malden MA, US Chao Lin - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 39/29 A61K 38/43 G01N 33/53 C12N 9/00
US Classification:
4242281, 435 71, 435183, 514 2, 514 12
Abstract:
The invention relates to the X-ray crystal structure of the hepatitis C virus helicase domain. More specifically, the invention relates to crystallized complexes of HCV helicase and an oligonucleotide, to crystallizable compositions of HCV helicase and an oligonucleotide and to methods of crystallizing an HCV helicase-oligonucleotide complex. The invention further relates to a computer programmed with the structure coordinates of the HCV helicase oligonucleotide binding pocket or the HCV helicase nucleotide triphosphate pocket wherein said computer is capable of displaying a three-dimensional representation of that binding pocket.
Chao Lin - Winchester MA, US Kai Lin - Waltham MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C12N 7/00 C07H 21/04
US Classification:
4242181, 536 231
Abstract:
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.
The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.
Chao Lin - Winchester MA, US Kai Lin - Waltham MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07H 23/00 C12N 7/00 C12Q 1/70
US Classification:
536 2371, 4353201, 435 691, 4352351, 435 6
Abstract:
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.
Combination Therapy For The Treatment Of Hcv Infection
Ann Kwong - Cambridge MA, US Nagraj Mani - Natick MA, US Yi Zhou - Lexington MA, US Chao Lin - Winchester MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A01N 43/04 A61K 31/70
US Classification:
514 49, 514 43, 514 50, 514 51
Abstract:
The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.
Crystallizable Compositions Comprising A Hepatitis C Virus Ns3 Protease Domain/Ns4A Complex
Joseph Kim - Natick MA, US Kurt Morgenstern - Derry NH, US Chao Lin - Cambridge MA, US Ted Fox - Maynard MA, US John Thomson - Belmont MA, US
Assignee:
Vertex Pharmaceuticals, Incorporated
International Classification:
C12Q001/70 C12N009/50 C12N007/00
US Classification:
435/005000, 435/219000, 435/235100
Abstract:
The present invention relates to compositions and crystals of a hepatitis C virus protease in complex with its viral cofactor. This invention also relates to methods of using the structure coordinates of hepatitis C virus protease in complex with a synthetic NS4A to solve the structure of similar or homologous proteins or protein complexes.
Chao Lin - Brookline MA, US Anne Kwong - Cambridge MA, US
International Classification:
C12Q001/68 C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
The present invention provides a method of accurately assaying the amount of nucleic acids in a biological source. According to another embodiment, the present invention provides a method of accurately assaying HCV in a biological source. The present invention also provides a method of simultaneously screening the effect of a plurality of compounds on the replication of a whole or part of a genome of a biological source. The present invention provides a method of simultaneously screening the effect of a plurality of compounds on the replication of the whole or part of the HCV genome in a biological source.
Name / Title
Company / Classification
Phones & Addresses
Chao H Lin Manager
The Stone House Shoppes Eating Places
822 S Robertson Blvd, Los Angeles, CA 90035
Chao Cheng Lin President
La Ni's Food Service, Inc
10460 Rosecrans Ave, Bellflower, CA 90706
Chao Lin President
Xundaex, Inc
1045 E Vly Blvd, San Gabriel, CA 91776 137 S 8 Ave, Whittier, CA 91746
Chao I. Lin President
Galant & Lin, M.D.'s, Inc
505 S Main St, Orange, CA 92868
Chao Chung Lin President
Pacific Carpet & Home Interiors Inc Ret Floor Covering
Keck Graduate Institute
Student Assistant
Baxter Healthcare Jun 2009 - Aug 2009
Intern
Baxter BioScience 2009 - 2009
Intern
Education:
Keck Graduate Institute of Applied Life Sciences 2009 - 2011
Master of Bioscience, Business of Bioscience, Medical Devices & Diagnostics
University of California, Los Angeles 2004 - 2009
BA, BS, Economics, Microbiology, Immunology, & Molecular Genetics
Saltire Entertainment LLC Feb 2009 - Apr 2009
Contracted Concept Artist
Radical Comics Feb 2009 - Mar 2009
Production Artist
Black Mana Studios Feb 2009 - Mar 2009
Contracted Concept and Matte Painting Artist
Fleishman-Hillard Jan 2009 - Feb 2009
Art Direction, Level Design.
Creo Ludus Entertainment, LLC Dec 2008 - Feb 2009
Contract Concept Artist
Education:
Art Center College of Design 2004 - 2008
The Gnomon School of Visual Effect 2006 - 2006
Electrical Engineer, Master's In Electrical Engineering Candidate, Case Western Reserve University
Research Assistant at Case Western Reserve University: Control & Energy Systems Center Lab Cleveland, Ohio
Location:
Cleveland, Ohio
Industry:
Electrical/Electronic Manufacturing
Work:
Case Western Reserve University: Control & Energy Systems Center Lab Cleveland, Ohio - Cleveland/Akron, Ohio Area since Aug 2012
Research Assistant
Education:
Case Western Reserve University 2012 - 2013
Master of Engineering (MEng), Electrical and Electronics Engineering
Abilene Christian University, Abilene, Texas 2009 - 2011
Bachelors of Science Engineering, Engineering Management
South China University of Technology 2006 - 2009
Bachelor of Engineering (B.Eng.), Electrical and Electronics Engineering
Nonlinear Ion Dynamics Panorama City, CA Jun 2014 to Oct 2014 Research EngineerUSC project Los Angeles, CA Mar 2013 to May 2013 Finite Element Analysis ProjectHUST Graduate Project Wuhan, China Mar 2012 to Jun 2012 Numerical Simulation DesignSichuan Air Separation Group Sichuan, China Jul 2011 to Sep 2011 Assistant Engineer Internship
Education:
University of Southern California Los Angeles, CA 2012 to 2014 Master of Science in Mechanical EngineeringHuazhong University of Science and Technology Wuhan, China 2008 to 2012 Bachelor of Science in Energy and Power Engineering
Skills:
ANSYS, SolidWorks, Abaqus, AutoCAD, MATLAB, MS Office, Programming C, Finite Element Analysis, Computational Fluid Dynamics, Mechanical Engineering Sciences, HVAC system, Computer Aided Design and Manufacturing, Japanese, Chinese-Mandarin, Java, C++, Python
lead author), Robert Scharpf and Paul Winnard. Collaborators from the Virginia Polytechnic Institute and State University are Ivan Akhrymuk (joint study lead author), Kylene Kehn-Hall, Lauren Panny and Amy Smith. Shih-Chao Lin from the National Taiwan Ocean University also contributed to the study.